1. Home
  2. MREO vs TITN Comparison

MREO vs TITN Comparison

Compare MREO & TITN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • TITN
  • Stock Information
  • Founded
  • MREO 2015
  • TITN 1980
  • Country
  • MREO United Kingdom
  • TITN United States
  • Employees
  • MREO N/A
  • TITN N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • TITN Other Specialty Stores
  • Sector
  • MREO Health Care
  • TITN Consumer Discretionary
  • Exchange
  • MREO Nasdaq
  • TITN Nasdaq
  • Market Cap
  • MREO 369.2M
  • TITN 341.6M
  • IPO Year
  • MREO N/A
  • TITN 2007
  • Fundamental
  • Price
  • MREO $2.30
  • TITN $16.34
  • Analyst Decision
  • MREO Strong Buy
  • TITN Buy
  • Analyst Count
  • MREO 7
  • TITN 5
  • Target Price
  • MREO $7.71
  • TITN $19.00
  • AVG Volume (30 Days)
  • MREO 1.7M
  • TITN 341.9K
  • Earning Date
  • MREO 05-14-2025
  • TITN 05-22-2025
  • Dividend Yield
  • MREO N/A
  • TITN N/A
  • EPS Growth
  • MREO N/A
  • TITN N/A
  • EPS
  • MREO N/A
  • TITN N/A
  • Revenue
  • MREO N/A
  • TITN $2,702,122,000.00
  • Revenue This Year
  • MREO N/A
  • TITN N/A
  • Revenue Next Year
  • MREO $61.92
  • TITN $3.22
  • P/E Ratio
  • MREO N/A
  • TITN N/A
  • Revenue Growth
  • MREO N/A
  • TITN N/A
  • 52 Week Low
  • MREO $1.58
  • TITN $12.30
  • 52 Week High
  • MREO $5.02
  • TITN $24.28
  • Technical
  • Relative Strength Index (RSI)
  • MREO 52.99
  • TITN 51.89
  • Support Level
  • MREO $1.58
  • TITN $15.68
  • Resistance Level
  • MREO $2.37
  • TITN $16.78
  • Average True Range (ATR)
  • MREO 0.21
  • TITN 1.10
  • MACD
  • MREO 0.04
  • TITN 0.06
  • Stochastic Oscillator
  • MREO 91.19
  • TITN 77.38

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

Share on Social Networks: